About C2N DIAGNOSTICS LLC
C2N Diagnostics is a specialty diagnostics company providing laboratory services and products focused on brain health, particularly in the field of Alzheimer’s disease. They develop and commercialize blood tests, such as the PrecivityAD® and PrecivityAD2™ tests, to assess brain amyloid pathology and aid in medical management and treatment decisions.
State-of-the-art proprietary liquid-chromatography-tandem mass spectrometry (LC-MS/MS) methodologiesDevelopment and commercialization of novel diagnostics for Alzheimer’s disease and related forms of neurodegenerationClinical decision-making support through biomarker products for diagnosis and treatment monitoringMaximizing the quality and efficiency of clinical trials for neurodegeneration treatmentsProviding innovative tools for healthcare researchers to understand disease mechanisms and identify new treatment targets
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to C2N DIAGNOSTICS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.